phase i/ii trial of gv20-0251, a novel checkpoint inhibitor, in solid tumors
Published 7 hours ago • 17 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:37:42
the science of precognition | dr. julia mossbridge
-
0:43
management of residual disease in triple negative breast cancer
-
36:34
9 23 2024
-
2:39
there are still 'many unknowns' about efficacy of potential coronavirus vaccines, professor says
-
19:42
how mercedes’ wind tunnel mistake ended their f1 dominance
-
1:40:06
woodstock for the adventurous and responsible | bret weinstein & heather heying | ep 483
-
7:41
prosecutors unleash explosive letter about trump’s alleged gunman!
-
0:07
dr. edwin asturias: "i got vaccinated for ... "
-
3:25
therapeutic options in metastatic triple-negative breast cancer
-
0:52
extended follow-up of ambassador: adjuvant pembrolizumab in miuc
-
0:50
patient-friendly radiation courses in breast cancer
-
0:50
corona psa listen to the experts
-
0:54
de-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer
-
2:34
cdc: less than 0.01% of vaccinated people have developed covid 'breakthrough' infections that have l
-
31:41
the pursuit of precision: the science advancing individualized medicine - vaccines for cancer
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
17:19
the inequities of covid-19: a focus on public housing
-
0:17
'cancer can be prevented too' - vaccination
-
0:41
what are claire's concerns for the future?
-
1:02
the impact of long covid on livelihoods
-
17:02
biomarkers indication for reinfection peter a crisologo